Healthcare - Biotechnology - NASDAQ - NL
$ 20.35
-0.973 %
$ 1.1 B
Market Cap
-7.37
P/E
INCOME STATEMENT
0
REVENUE
-96.9 M
OPERATING INCOME
-99.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Pharvaris N.V.
| Revenue | 0 |
| Cost Of Revenue | 252 K |
| Gross Profit | -252 K |
| Operating Expenses | 96.9 M |
| Operating Income | -96.9 M |
| Other Expenses | 2.91 M |
| Net Income | -99.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.3 | 0.2 | 80.5 K | 0 | 547 | 0 |
| Gross Profit | (0.3) | (0.2) | 80.5 K | 0 | 547 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 96.9 | 86.7 | 54.1 | 25.0 | 8.0 | 4.3 |
| Selling, General and Administrative Expenses | 31.3 | 29.3 | 18.3 | 5.5 | 2.3 | 0.7 |
| Research and Development Expenses | 65.6 | 57.4 | 35.8 | 19.5 | 5.7 | 3.6 |
| Operating Income | (96.9) | (86.7) | (65.9) | (25.0) | (8.0) | (4.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 20.1 K | 16.1 K | 0.3 | 92.5 K | 0 | 0 |
| Total Other Income | (2.9) | 11.1 | 11.5 | (1.1) | 16.9 K | 380 |
| Pre-Tax Income | (99.8) | (75.7) | (42.7) | (26.1) | (8.0) | (4.3) |
| NET INCOME | ||||||
| Tax Provision | 1.0 | 0.7 | 70.1 K | 83.3 K | 16.9 K | 380 |
| Net Income | (100.9) | (76.3) | (42.7) | (26.0) | (8.0) | (4.3) |
| EPS | 2.63 | 2.27 | 1.41 | 0.85 | 1.66 | 0.14 |